Levomequitazine | m-entrepreneurship.com

Product Name :
Levomequitazine

Search keywords :
Mequitazine

drugId :
null

Target Vo:
Histamine receptor

Target Vo Short Name :
Histamine receptor

Moa_Name:
Histamine receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pierre Fabre Ltd

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Rhinitis, Allergic, Seasonal

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ERK1/2 (Thr202/Tyr204)/(Thr185/Tyr187) Antibody
FDFT1 Antibody
AFP Antibody (YA914): AFP Antibody (YA914) is an unconjugated, approximately 65 kDa, mouse-derived, anti-AFP (YA914) monoclonal antibody. AFP Antibody (YA914) can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, rat, background without labeling.

Author: Betaine hydrochloride

Related Posts